Plaque Volume Over Stenosis Degree

Paradigms are bound to eventually change. After years blinded by stenosis degree, plaque volume has proven to be a better predictor of cardiovascular events and death. Thus, patients with similar degrees of atherosclerosis burden have a similar prognosis, regardless of their lesions being obstructive or not.

El volumen de placa por sobre el grado de estenosis

The aim of this work was to assess whether obstructive disease has an additional predictive value beyond its association with the total number of calcified atherosclerotic lesions evaluated by tomography.

This analysis, recently published in JACC, included 23,759 symptomatic patients diagnosed by angiography. Major cardiovascular events (infarction, stroke, and all-cause mortality) were stratified by atherosclerotic burden and number of affected vessels.

After a median follow-up of 4.3 years, 1054 patients experienced their first cardiovascular event. The event rate increased with both higher calcium scores and higher number of affected vessels. With a calcium score of 0, the event rate was 6.2 patients per 1000, while a >1000 score indicated a risk of 42.3 patients per 1000.

Having 1 affected vessel provided a similar risk of events than a calcium score of 0 (6.1 patients per 1000), while having all 3 vessels affected was not as severe as a calcium score >1000 (34.7 patients per 1000).


Read also: Sapien 3 Performs Well in “Jobs” for Which It Is Not Designed.


After stratifying patients into 5 groups according to their calcium score (0, 1-99, 100-399, 400-1000, and >1000), the presence of obstructive disease was not associated with a higher risk when compared with patients without obstructive disease.

Conclusion

Plaque volume, and not stenosis per se, is the best predictor for cardiovascular events and death.

j-jacc-2020-10-021free

Original title: Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.

Reference: Martin Bødtker Mortensen et al. J Am Coll Cardiol 2020;76:2803–13 https://doi.org/10.1016/j.jacc.2020.10.021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...